
Insulet Corporation PODD
$ 175.04
1.68%
Quarterly report 2025-Q3
added 04-18-2026
Insulet Corporation Accounts Payables 2011-2026 | PODD
Accounts payable — are the obligations of an organization to other legal entities or individuals that arise in cases when the company has acquired goods or services on deferred payment terms, has not paid taxes and fees, has wage arrears to employees, or has received loans and other liabilities. Accounts payable arise when an organization has already received some benefit but has not yet paid for it.Main types of accounts payable
| Type of liability | Example |
|---|---|
| To suppliers and contractors | Goods received but not yet paid for |
| Taxes and fees | VAT, income tax, etc., not paid on time |
| Salaries | Employee wages not paid |
| To budgets | Insurance contributions to funds not paid |
| To founders | Founders provided borrowed funds |
| To banks | Overdue loan payments |
| Other | Fines, penalties, forfeits, customer prepayments, etc. |
Impact on the company's financial performance
- Liquidity and solvency
Accounts payable are part of short-term liabilities, so they affect liquidity ratios - Financial stability
The higher the share of borrowed funds (including accounts payable), the lower the company's level of independence - Capital turnover
Moderate accounts payable can positively affect working capital by allowing the company to use “free” financing from suppliers (payment deferrals) - Risks and reputation
Large and especially overdue accounts payable may indicate financial difficulties. This can deter investors, partners, and lenders, and at a critical level of debt and lack of resources to repay it, bankruptcy proceedings may be initiated
Annual Accounts Payables Insulet Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 75 M | 19.8 M | 19.2 M | 30.8 M | 37.7 M | 54.1 M | 54.5 M | 25.5 M | 24.4 M | 13.2 M | 15.2 M | 14.7 M | 19.4 M | 9.36 M | 11.4 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 75 M | 9.36 M | 28.3 M |
Quarterly Accounts Payables Insulet Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 48.2 M | 96.1 M | 57.6 M | 19.8 M | 40.3 M | 76.8 M | 75.9 M | 19.2 M | 77.8 M | 108 M | 85.9 M | 30.8 M | 62.1 M | 57.2 M | 52.2 M | 37.7 M | 58 M | 49.3 M | 59.1 M | 54.1 M | 57 M | 35.6 M | 36.4 M | 54.5 M | 54.5 M | 54.5 M | 54.5 M | 25.5 M | 25.5 M | 25.5 M | 25.5 M | 24.4 M | 24.4 M | 24.4 M | 24.4 M | 13.2 M | 13.2 M | 13.2 M | 13.2 M | 15.2 M | 15.2 M | 15.2 M | 15.2 M | 12.6 M | 14.7 M | 14.7 M | 14.7 M | 19.4 M | 19.4 M | 19.4 M | 19.4 M | 9.36 M | 9.36 M | 9.36 M | 9.36 M | 11.4 M | 11.4 M | 11.4 M | 11.4 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 108 M | 9.36 M | 34.6 M |
Accounts Payables of other stocks in the Medical devices industry
| Issuer | Accounts Payables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AdaptHealth Corp.
AHCO
|
352 M | $ 13.17 | 0.46 % | $ 1.78 B | ||
|
BIOLASE
BIOL
|
6.06 M | - | -13.19 % | $ 166 K | ||
|
Allied Healthcare Products
AHPI
|
1.21 M | - | 3.58 % | $ 2.21 M | ||
|
Eargo
EAR
|
6.5 M | - | - | $ 10.2 M | ||
|
Delcath Systems
DCTH
|
2.66 M | $ 10.8 | 4.05 % | $ 387 M | ||
|
Apollo Endosurgery
APEN
|
7.42 M | - | - | $ 475 M | ||
|
Second Sight Medical Products
EYES
|
1.03 M | - | -0.97 % | $ 54.4 M | ||
|
Electromed
ELMD
|
2.67 M | $ 25.6 | -0.43 % | $ 216 M | ||
|
Avinger
AVGR
|
777 K | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
9.07 M | - | - | $ 3.31 B | ||
|
EDAP TMS S.A.
EDAP
|
5.71 M | $ 3.47 | 4.52 % | $ 130 M | ||
|
Aziyo Biologics
AZYO
|
4.79 M | - | 1.37 % | $ 20.5 M | ||
|
Helius Medical Technologies
HSDT
|
531 K | $ 2.12 | 3.92 % | $ 1.29 M | ||
|
Inspire Medical Systems
INSP
|
36.6 M | $ 56.7 | 1.0 % | $ 1.67 B | ||
|
Conformis
CFMS
|
4.16 M | - | - | $ 16.4 M | ||
|
LivaNova PLC
LIVN
|
97.2 M | $ 61.0 | 1.5 % | $ 3.33 B | ||
|
ClearPoint Neuro
CLPT
|
1.26 M | $ 11.37 | 1.7 % | $ 322 M | ||
|
Cardiovascular Systems
CSII
|
14.4 M | - | 0.15 % | $ 844 M | ||
|
Cytosorbents Corporation
CTSO
|
2.87 M | $ 0.61 | 0.36 % | $ 38 M | ||
|
Invacare Corporation
IVC
|
105 M | - | - | $ 24.7 M | ||
|
IRIDEX Corporation
IRIX
|
5.38 M | $ 1.03 | - | $ 17.4 M | ||
|
Dynatronics Corporation
DYNT
|
3.4 M | - | 14.99 % | $ 929 K | ||
|
OrthoPediatrics Corp.
KIDS
|
18.8 M | $ 15.65 | 3.92 % | $ 367 M | ||
|
Butterfly Network
BFLY
|
4.25 M | $ 5.4 | 12.97 % | $ 1.14 B | ||
|
GBS
GBS
|
1.47 M | - | -0.57 % | $ 7.12 M | ||
|
Sintx Technologies
SINT
|
382 K | $ 2.41 | 14.22 % | $ 6.68 M | ||
|
Globus Medical
GMED
|
98.9 M | $ 91.34 | 1.29 % | $ 12.4 B | ||
|
TransMedics Group
TMDX
|
10.4 M | $ 100.01 | -0.77 % | $ 3.4 B | ||
|
NanoVibronix
NAOV
|
719 K | - | - | $ 1.08 M | ||
|
CONMED Corporation
CNMD
|
93.6 M | $ 36.8 | 0.38 % | $ 1.14 B | ||
|
Integer Holdings Corporation
ITGR
|
113 M | $ 84.03 | -5.06 % | $ 2.92 B | ||
|
Stryker Corporation
SYK
|
1.8 B | $ 294.73 | -6.47 % | $ 113 B | ||
|
Edwards Lifesciences Corporation
EW
|
228 M | $ 83.98 | 0.57 % | $ 49.1 B | ||
|
Tandem Diabetes Care
TNDM
|
47.1 M | $ 19.41 | -0.61 % | $ 1.32 B | ||
|
LENSAR
LNSR
|
19 M | $ 5.61 | 7.27 % | $ 67.1 M | ||
|
Pulmonx Corporation
LUNG
|
3.9 M | $ 1.35 | 5.47 % | $ 54.9 M | ||
|
MiMedx Group
MDXG
|
14.5 M | $ 3.68 | 9.52 % | $ 544 M | ||
|
Myomo
MYO
|
1.51 M | $ 0.9 | 4.16 % | $ 37.7 M |